Unknown

Dataset Information

0

Desulfovibrio legallii prosthetic shoulder joint infection and review of antimicrobial susceptibility and clinical characteristics of Desulfovibrio infections.

ABSTRACT: We describe a case of shoulder hemiarthroplasty infection with Desulfovibrio legallii. Antimicrobial susceptibilities of 36 Desulfovibrio isolates are presented. Metronidazole and carbapenems exhibited reliable activity, although piperacillin-tazobactam did not. Eleven previous cases of Desulfovibrio infection are reviewed; most arose from a gastrointestinal tract-related source.

SUBMITTER: Vasoo S 

PROVIDER: S-EPMC4136176 | biostudies-literature | 2014 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Desulfovibrio legallii prosthetic shoulder joint infection and review of antimicrobial susceptibility and clinical characteristics of Desulfovibrio infections.

Vasoo Shawn S   Mason Erin L EL   Gustafson Daniel R DR   Cunningham Scott A SA   Cole Nicolynn C NC   Vetter Emily A EA   Steinmann Scott P SP   Wilson Walter R WR   Patel Robin R   Berbari Elie F EF   Henry Nancy K NK  

Journal of clinical microbiology 20140521 8

We describe a case of shoulder hemiarthroplasty infection with Desulfovibrio legallii. Antimicrobial susceptibilities of 36 Desulfovibrio isolates are presented. Metronidazole and carbapenems exhibited reliable activity, although piperacillin-tazobactam did not. Eleven previous cases of Desulfovibrio infection are reviewed; most arose from a gastrointestinal tract-related source. ...[more]

Similar Datasets

Unknown Prosthetic joint infections in shoulder and elbow: An evaluation of micro-organisms in periprosthetic shoulder and elbow joint infections across the United Kingdom.
| S-EPMC12689352 | biostudies-literature
Unknown <i>Staphylococcus saccharolyticus</i> Associated with Prosthetic Joint Infections: Clinical Features and Genomic Characteristics.
| S-EPMC8066136 | biostudies-literature
Unknown Early aseptic reoperation after shoulder arthroplasty increases risk of subsequent prosthetic joint infection.
| S-EPMC8568807 | biostudies-literature
Unknown Clinical Experience with Tigecycline in the Treatment of Prosthetic Joint Infections.
| S-EPMC6536800 | biostudies-literature
Unknown Mycobacterium abscessus Prosthetic Joint Infections of the Knee.
| S-EPMC6831809 | biostudies-literature
Unknown Clinical Experience With a Coordinated Multidisciplinary Approach to Treating Prosthetic Joint Infection.
| S-EPMC7298531 | biostudies-literature
Unknown Variation in the IL1B, TNF and IL6 genes and individual susceptibility to prosthetic joint infection.
| S-EPMC3475038 | biostudies-literature
Unknown Risk of Treatment Failure for Prosthetic Joint Infections: Retrospective Chart Review in an Outpatient Parenteral Antimicrobial Therapy Program.
| S-EPMC9817224 | biostudies-literature
Unknown The Location of Biofilms on Chronic Prosthetic Joint Infections and the Ramifications for Clinical Practice.
| S-EPMC10839572 | biostudies-literature
Unknown Human prosthetic joint infections are associated with myeloid-derived suppressor cells (MDSCs): Implications for infection persistence.
| S-EPMC5953848 | biostudies-literature